Jeffrey Testani, MD
Yale University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jeffrey Testani, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:06 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07281014 · Unmitigated Aldosterone Signaling During Standard Clinical MRA DosingYale University · active not recruiting · Heart Failure · principal investigator
- N/ANCT06872645 · Exploring Water-free Sodium StorageYale University · recruiting · Peritoneal Dialysis, Heart Failure · principal investigator
- Ph2NCT06815471 · CRF2 Agonist for the Treatment of Worsening Heart FailureCorteria Pharmaceuticals · suspended · Worsening Heart Failure · study chair
- Ph1NCT06209359 · Mechanisms of Diuretic Resistance in Heart Failure, Aim 3Yale University · recruiting · Heart Failure, Diuretic Resistance · principal investigator
- Ph2NCT05726032 · Empagliflozin in Patients With Cirrhosis and AscitesYale University · recruiting · Cirrhosis, Liver Failure · principal investigator
- Ph4NCT05671991 · Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal DiseaseYale University · active not recruiting · End Stage Renal Disease on Dialysis · principal investigator
- Ph1NCT05553938 · Effects of Acute and Chronic Empagliflozin Heart FailureYale University · active not recruiting · Heart Failure · principal investigator
- Ph2NCT04438213 · Ertugliflozin in Chronic Heart FailureYale University · recruiting · Heart Failure · principal investigator
- Ph1NCT03093090 · Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: FurosemideYale University · withdrawn · Medication Absorption · principal investigator
- Ph1NCT03027960 · Empagliflozin in Heart Failure: Diuretic and Cardio-Renal EffectsYale University · completed · Heart Failure, Type II; Diabetes · principal investigator
- Ph1NCT02546583 · Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart FailureYale University · completed · Heart Failure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Exploring water free sodium storageR01DK138155 · NIDDK · YALE UNIVERSITY · PI JEFFREY M TESTANI · fiscal years 2024 to 2026Named on NCT06872645
- Mechanisms of diuretic resistance in heart failureR01DK130997 · NIDDK · YALE UNIVERSITY · PI JEFFREY M TESTANI · fiscal years 2022 to 2026Named on NCT06209359
- Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart FailureR01HL128973 · NHLBI · YALE UNIVERSITY · PI JEFFREY M TESTANI · fiscal years 2015 to 2019Named on NCT02546583
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.